|Year End||30 September|
|Annual General Meeting||February|
|Dividend Paid||Quarterly (January, April, July, October)|
James Long was appointed a Director on 1 May 2006 and Chairman on 26 February 2015. James was formerly Director of Risk and Compliance for AstraZeneca Europe, Corporate Finance Director of Inchcape plc and Managing Director, Asia and Emerging Markets, for the ESAB Group.